Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41 (Q81396903)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2005

Language	Label	Description	Also known as
English	Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41	scientific article published on 01 March 2005

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Renaud Burrer

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sandrine Haessig-Einius

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Anne-Marie Aubertin

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Christiane Moog

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 March 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

333

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

102-113

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Bathophenanthroline Disulfonate and Soluble CD4 as Probes for Early Events of HIV Type 1 Entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Acquisition of host cell-surface-derived molecules by HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.12.034

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15708596%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81396903&oldid=1382276214"